Ravi Munuganti

Ravi Munuganti is a Senior Computational Chemist at Gandeeva Therapeutics in Canada, with a strong background in computational chemistry and AI/ML-driven drug discovery. He earned his PhD from the University of British Columbia and conducted postdoctoral research at the Vancouver Prostate Centre. Following this, he worked at Xenon Pharmaceuticals, a neuroscience-focused biopharmaceutical company. Ravi has substantial experience in developing novel therapeutic candidates targeting kinases, transcription factors, and ion channels for oncology and neurological disorders. His goal is to make a significant impact in drug discovery through innovative research with potential clinical applications.